Optimizing Diet and Nutrition for Enhanced Anti-Obesity Medication Outcomes

The global prevalence of obesity continues to rise, leading to increased risks of type 2 diabetes, cardiovascular disease, and other metabolic disorders. Anti-obesity medications (AOMs), such as GLP-1 receptor agonists, have emerged as powerful tools for weight management. However, there remains a significant gap in understanding how specific dietary strategies and nutritional considerations can be optimally integrated with AOM use to maximize efficacy, preserve lean mass, and prevent nutrient deficiencies.

The review highlighted that combining AOMs with structured dietary interventions significantly enhances overall weight loss and improves body composition. Patients on GLP-1 receptor agonists typically achieve 15-25% total body weight loss, which can be further boosted by an additional 5-10% with concurrent adherence to a nutrient-dense diet. Specific dietary patterns, particularly those emphasizing high protein intake (25-30% of total calories) and ample fiber, were found to be crucial for preserving lean muscle mass, limiting its loss to <5% compared to 10-15% in less guided approaches. Proactive nutritional counseling was identified as essential for mitigating potential adverse effects and preventing deficiencies. > The most critical finding was that personalized dietary guidance, focusing on nutrient density and targeted supplementation, is paramount for optimizing long-term weight management success and preventing common micronutrient deficiencies like vitamin D (30-40% prevalence) and iron (15-20% prevalence) in AOM users, significantly higher than the <10% observed in well-managed controls.